References
- Weinberg GL, VadeBoncouer T, Ramaraju GA, et al. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology. 1998;88:1071–1075.
- Levine M, Hoffman RS, Lavergne V, et al. Systematic review of the effect of intravenous lipid emulsion therapy for non-local anesthetics toxicity. Clin Toxicol. 2016;54:194–221.
- Lonnquist PA. Toxicity of local anesthetic drugs: a pediatric perspective. Pediatr Anaesth. 2012;22:39–43.
- Breschan C, Hellstrand E, Likar R, et al. Early signs of toxicity and ‘‘subtoxic’’ conditions in infant monitoring: bupivacaine plasma levels following caudal anesthesia. Anaesthesist. 1998;47:290–294.
- Rosenblatt MA, Abel M, Fischer GW, et al. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology. 2006;105:217–218.
- Weinberg G, Ripper R, Feinstein D, et al. Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med. 2003;28:198–202.
- Harvey M, Cave G. Lipid rescue: does the sink hold water? And other controversies. Br J Anaesth. 2014;112:622–625.
- Hoegberg LC, Bania TC, Lavergne V, et al. Systematic review of the effect of intravenous lipid emulsion therapy for local anesthetic toxicity. Clin Toxicol. 2016;54:167–193.
- Sirianni AJ, Osterhoudt KC, Calello DP, et al. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med. 2008;51:412–415.
- Cave G, Harvey M, Willres J, et al. LIPAEMIC report: results of clinical use of intravenous lipid emulsion in drug toxicity reported to an online lipid registry. J Med Toxicol. 2014;10:133–142.
- Levine M, Skolnik AB, Ruha AM, et al. Complications following antidotal use of intravenous lipid emulsion therapy. J Med Toxicol. 2014;10:10–14.
- Bucklin MH, Gorodetsky RM, Wiegand TJ. Prolonged lipemia and pancreatitis due to extended infusion of lipid emulsion in bupropion overdose. Clin Toxicol. 2013;51:896–898.
- Martin C, Gonzalez H, Ruiz S, et al. Acute respiratory distress syndrome following verapamil overdose treated with intravenous lipid emulsion: a rare life-threatening complication. Ann Fr Anesth Reanim. 2014;33:101–102.
- Rodriguez B, Wilheim A, Kokko KE. Lipid emulsion use precluding renal replacement therapy. J Emerg Med. 2014;47:635–637.
- Schulz PE, Weiner SP, Haber LM, et al. Neurological complications from fat emulsion therapy. Ann Neurol. 1994;35:628–630.
- Kessler U, Poeschl J, Raz D, et al. Effects of intralipid infusion on blood viscosity and other haemorheological parameters in neonates and children. Acta Paediatr. 2004;93:1058–1062.
- Johnson-Arbor K, Salinger L, Luczycki S. Prolonged laboratory interference after administration of intravenous lipid emulsion therapy. J Med Toxicol. 2015;11:223–226.
- Grunbaum AM, Gilfix BM, Hoffman RS, et al. Review of the effect of intravenous lipid emulsion on laboratory analyses. Clin Toxicol. 2016;54:92–102.
- American College of Medical Toxicology. ACMT position statement: guidance for the use of intravenous lipid emulsion. J Med Toxicol. Forthcoming.
- Gosselin S, Hoegberg LC, Hoffman RS, et al, Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning. Clin Toxicol. 2016;54:899--923.
- A. Fresenius Kabi AB. Intralipid 20% I.V. Fat Emulsion Package Insert. 2007. p. 3–20.
- Hiller DB, Di Gregorio G, Kelly K, et al. Safety of high volume lipid emulsion infusion: a first approximation of LD50 in rats. Reg Anesth Pain Med. 2010; 35:140–144.
- Fettiplace MR, Akpa BS, Rubinstein I, et al. Confusion about infusion: rational volume limits for intravenous lipid emulsion during treatment of oral overdoses. Ann Emerg Med. 2015; 66:185–188.